Abstract

BackgroundTimely HIV testing and initiation of antiretroviral therapy are two major determinants of survival for HIV-infected individuals. Our study aimed to explore the trend of late HIV/AIDS diagnoses and to assess the factors associated with these late diagnoses in China between 2006 and 2014.MethodsWe used data from the Chinese Comprehensive Response Information Management System of HIV/AIDS (CRIMS). All individuals who tested positive for HIV between 2006 and 2014 in China and were at least 15 years of age were included. A late diagnosis was defined as an instance in which an individual was diagnosed as having AIDS or WHO stage 3 or 4 HIV/AIDS, or had a CD4 cell count less than 200 cells/mm3 at the time of diagnosis.ResultsAmong the 528,234 individuals (≥15 years old) newly diagnosed with HIV between 2006 and 2014, 179,700 (34.0%) people were considered to have received late diagnoses. The late diagnosis rate decreased from 33.9% in 2006 to 29.7% in 2014 (P < 0.01). Late diagnoses were more likely to be found among those who were 45–54 years old (adjusted odds ratio [aOR]: 3.25, 95% confidence interval [CI]: 3.17–3.34) or 55+ years old (OR: 2.94, 95% CI: 2.86–3.02), male (aOR: 1.15, 95% CI: 1.13,1.17), employed as a farmer or rural laborer (aOR: 1.13, 95% CI: 1.11–1.14), infected through blood or plasma transfusion (aOR: 4.18, 95% CI: 4.02, 4.35), diagnosed at hospitals (OR: 1.17, 95% CI: 1.15, 1.19), of Han ethnicity (aOR: 1.30, 95% CI: 1.28, 1.32), and married (OR: 1.12, 95% CI: 1.11,1.13). Of those people living with HIV (PLHIV) who received late diagnoses, 7.4%(8637) and 46.1%(28,462) ultimately died with or without receiving antiretroviral therapy within a year of diagnosis, respectively.ConclusionA large proportion of individuals with HIV/AIDS receive late diagnoses, and this proportion has witnessed a slight decline in recent years. Expanded testing is needed to increase early HIV diagnosis and antiretroviral therapy should be recommended to all diagnosed individuals as early as possible to reduce AIDS-related death.

Highlights

  • Human Immunodeficiency Virus (HIV) testing and initiation of antiretroviral therapy are two major determinants of survival for HIV-infected individuals

  • Prompt linkages with health care systems at the start of antiretroviral therapy (ART) yields the maximum benefits of HIV medical treatment for people living with HIV (PLHIV) [9] while decreasing the sexual transmission rate of HIV [10,11,12,13]

  • Our study aimed to identify characteristics and trends of cases of late HIV/AIDS diagnosis, and to assess the factors associated with late diagnosis, early mortality, and ART initiation in China between 2006 and 2014

Read more

Summary

Introduction

HIV testing and initiation of antiretroviral therapy are two major determinants of survival for HIV-infected individuals. ART is associated with a better prognosis among HIV-infected individuals and lower rates of disease progression [8]. Prompt linkages with health care systems at the start of ART yields the maximum benefits of HIV medical treatment for people living with HIV (PLHIV) [9] while decreasing the sexual transmission rate of HIV [10,11,12,13]. In the absence of timely initiation of ART, the majority of patients will suffer the deleterious effects of HIV infection due to the gradual failure of the immune system, ranging from infection by opportunistic diseases to even death. The propensity for HIV transmission by untested and unaware PLHIV is greater [14, 15] than for those made aware of their HIV status

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call